Valor202020212022202320242025TTMDespesas comerciais, gerais e administrativas735.27 M796.39 M850.75 M901.89 M1.03 B1.05 B1.09 BPesquisa e desenvolvimento141.25 M161.01 M254.82 M190.95 M219.79 M251.21 M257.93 MLucro operacional694.52 M932.03 M898.76 M1.1 B1.13 B1.36 B1.41 BLucro não operacional, total600 K-2.1 M-3.4 M-1.1 M-4.5 M-4.2 M—Despesa com juros, líquida de juros capitalizados33.13 M29.81 M39.86 M41.58 M31.2 M38.85 M38.93 MReceitas não operacionais, líquidas das despesas com juros-32.52 M-31.91 M-43.26 M-42.68 M-35.7 M-43.05 M—Receitas/despesas incomuns———————Lucro antes dos impostos661.99 M902.65 M859.97 M1.06 B1.11 B1.32 B1.37 BParticipação no lucro———————Impostos79.85 M157.81 M180.88 M216.13 M221.96 M264.73 M274.31 MParticipação de minoritários355 K-1 00000———Outras receitas/despesas após impostos———————Lucro líquido antes das operações descontinuadas581.78 M744.85 M679.09 M845.04 M887.87 M1.06 B1.1 BOperações descontinuadas———————Lucro líquido581.78 M744.85 M679.09 M845.04 M887.87 M1.06 B1.1 BAjuste de diluição———————Dividendos de ações preferenciais———————Lucro líquido diluído disponível aos acionistas581.78 M744.85 M679.09 M845.04 M887.87 M1.06 B1.1 BLucro básico por ação6.828.748.1210.1710.7713.1713.69Lucro diluído por ação6.718.68.0310.0610.6713.0813.59Número médio de ações básicas85.34 M85.2 M83.62 M83.07 M82.47 M80.43 M—Ações diluídas86.72 M86.57 M84.6 M83.98 M83.25 M81.03 M—EBITDA687.18 M1.57 B1.67 B1.84 B1.24 B1.49 B1.54 BEBIT591.18 M1.47 B1.55 B1.73 B1.11 B1.34 B1.39 BCusto da receita1.14 B1.33 B1.36 B1.47 B1.53 B1.65 B1.7 BOutros componentes do custo———————Amortização e depreciação (fluxo de caixa)96 M104.6 M111.9 M114.91 M129.94 M145.18 M148.8 M
IDEXX Laboratories, Inc. - Common Stock
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.